Achieving value and sustainability in prescribing medication: consultation

Closes 8 Sep 2024

This service needs cookies enabled.

Omega 3 fatty acids excluding icosapent ethyl [Vazkepa®]

Recommendations

  • do not initiate in primary or secondare care
  • deprescribe in all individuals currently prescribed this item
12a. Do you agree or disagree with the recommendation that prescribers should not initiate omega 3 fatty acids for any new individuals?
12b. Do you agree or disagree with the recommendation to deprescribe omega 3 fatty acids in all individuals?
12c. Please provide any further comments on the recommendations for omega 3 fatty acids